MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ: MIRA · IEX Real-Time Price · USD

0.689

-0.097 (-12.37%)

At close: Jul 19, 2024, 4:00 PM

0.661

-0.028 (-4.05%)

Pre-market: Jul 22, 2024, 7:06 AM EDT

MIRA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	6.89	6.95	4.7	1.47
Research & Development	2.06	1.57	2.35	0.68
Operating Expenses	8.95	8.53	7.05	2.15
Operating Income	-8.95	-8.53	-7.05	-2.15
Interest Expense / Income	3.4	3.46	0.01	0.02
Pretax Income	-12.36	-11.98	-7.06	-2.18
Net Income	-12.36	-11.98	-7.06	-2.18
Shares Outstanding (Basic)	20	19	18	-
Shares Outstanding (Diluted)	20	19	18	-
Shares Change	11.03%	5.69%	-	-
EPS (Basic)	-0.67	-0.64	-0.40	-
EPS (Diluted)	-0.67	-0.64	-0.40	-
Free Cash Flow	-4.51	-4.53	-5.6	-1.38
Free Cash Flow Per Share	-0.23	-0.24	-0.32	-
EBITDA	-8.95	-8.53	-7.05	-2.15
EBIT	-8.95	-8.53	-7.05	-2.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).